Table 1.
Demographics, visual acuity, foveal thickness, and hemoglobin A1c (HbA1c) results before and after nepafenac treatment
| Patient | Age sex | Eye | Baseline vision | Final vision | Days to final vision | Baseline foveal thickness (μm) | Final foveal thickness (μm) | Days to final foveal thickness | Initial Hba1c% | Final HbA1c% |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 65 M | OS | 20/80 | 20/50 | 193 | 378 | 215 | 193 | 7.0 | 6.8 |
| 2 | 68 M | OS | 20/40 | 20/40 | 209 | 286 | 226 | 209 | 6.5 | 6.8 |
| 3 | 66 F | OS | 20/240 | 20/140 | 259 | 517 | 158 | 259 | 7.3 | 9.4 |
| 4 | 68 F | OS | 20/120 | 20/80 | 227 | 599 | 423 | 227 | 4.9 | 6.0 |
| 5 | 76 M | OD | 20/80 | 20/70 | 182 | 342 | 267 | 91 | ||
| 5 | OS | 20/400 | 20/400 | 182 | 380 | 310 | 91 |